Latest News

With a median price-to-sales (or "P/S") ratio of close to 0.3x in the Metals and Mining industry in Korea, you could be...

In late January 2026, Clarivate Plc fully redeemed the remaining US$100 million of its 4.50% senior secured notes due 2026 using cash on hand, while also repurchasing about 56 million shares for US$225 million over 2025. The company also launched Clarivate Nexus, an AI-powered academic assistant aimed at helping students and researchers access trusted library content and discovery tools, underscoring its push to blend AI with its information services platform. We’ll now examine how...

Mitsuuroko Group HoldingsLtd (TSE:8131) has reported Q3 2026 revenue of ¥84.6 billion and basic EPS of ¥31.38, with trailing twelve month EPS at ¥207.59 and net income of ¥11.7 billion highlighting the scale of recent profitability. The company has seen revenue move from ¥81.3 billion in Q2 2025 to ¥97.2 billion in Q4 2025, then to ¥84.6 billion in Q3 2026, while quarterly basic EPS ranged from ¥12.10 in Q2 2025 to ¥92.14 in Q4 2025 before settling around the low ¥30s this year. This sets up...

Despite an already strong run, JX Advanced Metals Corporation ( TSE:5016 ) shares have been powering on, with a gain of...

Q3 2026 earnings snapshot and how the story is evolving WorkmanLtd (TSE:7564) has put up a punchy set of Q3 2026 numbers, with revenue of ¥48,166 million and basic EPS of ¥83.44, against a backdrop of 25.1% earnings growth over the past year and a net profit margin sitting at 13%. The company has seen revenue move from ¥41,810 million in Q3 2025 to ¥48,166 million in Q3 2026, while quarterly EPS has shifted from ¥67.25 to ¥83.44 over the same period. This sets up this quarter as a clean read...

FY 2025 headline results for Oenon Holdings (TSE:2533) Oenon Holdings (TSE:2533) has wrapped up FY 2025 with fourth quarter revenue of ¥24,446 million and basic EPS of ¥13.53, alongside net income of ¥763 million, putting concrete numbers around its latest earnings update. The company has seen quarterly revenue move from ¥20,227 million in Q3 FY 2024 to ¥23,638 million in Q4 FY 2024 and then to ¥24,446 million in Q4 FY 2025. Basic EPS shifted from ¥6.07 to ¥19.56 to ¥13.53 over the same...

JAPAN MATERIAL (TSE:6055) has reported another solid quarterly result for Q3 2026, with revenue of ¥16.1b and basic EPS of ¥27.26, set against trailing twelve month revenue of ¥59.1b and EPS of ¥98.19. The company’s revenue increased from ¥12.3b in Q3 2025 to ¥16.1b in Q3 2026, while quarterly EPS rose from ¥19.01 to ¥27.26 over the same period. Trailing net profit margin stands at 17.1% compared with 14% a year ago, and earnings are up 51.1% over that time, which points to a set of results...

It's not a stretch to say that Tongyang Pile Inc.'s ( KOSDAQ:228340 ) price-to-sales (or "P/S") ratio of 0.8x right now...

Ichinen Holdings Co.,Ltd. ( TSE:9619 ) has announced that it will be increasing its dividend from last year's...

Samyoung Co.,Ltd. ( KRX:003720 ) shareholders have had their patience rewarded with a 46% share price jump in the last...

Ajinextek Co., Ltd. ( KOSDAQ:059120 ) shareholders might be concerned after seeing the share price drop 17% in the last...

N2Tech Co.,Ltd ( KOSDAQ:227950 ) shares have had a really impressive month, gaining 29% after a shaky period...

Nexen Corporation ( KRX:005720 ) shareholders would be excited to see that the share price has had a great month...

ORION (KRX:271560) has had a great run on the share market with its stock up by a significant 22% over the last month...

Nuintek Co.,Ltd. ( KOSDAQ:012340 ) shareholders have had their patience rewarded with a 34% share price jump in the...

It hasn't been the best quarter for Etherstack plc ( ASX:ESK ) shareholders, since the share price has fallen 17% in...

Argo Investments Limited ( ASX:ARG ) will pay a dividend of A$0.185 on the 20th of March. Based on this payment, the...

Key Insights Significantly high institutional ownership implies Horizon Gold's stock price is sensitive to their...

Diversified Energy (DEC) has completed a US$200 million tap-on offering of 9.75% senior secured bonds in the Nordic market, a move that directly affects its capital structure and funding flexibility. See our latest analysis for Diversified Energy. The bond tap comes after a period of weaker share price momentum, with a 90 day share price return showing a decline of 10.39% and a 1 year total shareholder return showing a decline of 16.86%. This points to pressure that has built up over several...

Canon Inc. recently announced a series of moves, including the promotion of Executive Vice President Kazuto Ogawa to president and chief operating officer in March 2026, a new share repurchase program of up to ¥200,000 million for as many as 54,000,000 shares by January 2027, and updated guidance alongside its 2025 results. The company’s shift in leadership, combined with a return to quarterly profitability and a commitment to ongoing ¥80-per-share dividends, underscores a broad reset of...

Pfizer (NYSE:PFE) received FDA Priority Review for a potential HYMPAVZI label expansion for pediatric and inhibitor-positive hemophilia patients. The company launched TrumpRx, a new affordability initiative linked to a Most Favored Nation agreement in the US. Pfizer joined BaseLaunch to support early stage biotech ventures in Europe. For you as an investor, these updates sit at the core of what Pfizer does as a large, diversified pharma group, balancing mature products with newer therapies...

Ryan Specialty Holdings (RYAN) is heading into an earnings report with attention sharpened by several moving pieces, including contentious Florida insurance legislation, new insurance focused AI tools, and a fresh expansion push in Canada. See our latest analysis for Ryan Specialty Holdings. Despite the headline risk around Florida legislation and questions about how new AI tools could affect brokerage models, Ryan Specialty’s 1 day share price return of 2.51% to US$44.88 comes after a 30 day...

Musti Group Oyj (HLSE:MUSTI) has released its FY 2025 results with fourth quarter revenue of €142.0 million and basic EPS of €0.01, rounding out a year where the trailing twelve month figures show revenue of €514.9 million and a basic EPS loss of €0.11. Over recent quarters, the company has seen revenue move from €122.2 million and basic EPS of €0.08491 in Q4 2024 to €119.8 million with an EPS loss of €0.103712 in Q1 2025, before climbing to €142.0 million and EPS of €0.01 in Q4 2025. This...

United Therapeutics reported positive TETON-2 study results for inhaled treprostinil in idiopathic pulmonary fibrosis (IPF). The data indicate a potential role for inhaled treprostinil in helping stabilize lung function for IPF patients. The FDA qualified the PROLIFIC Risk Score, a tool designed to identify IPF patients at higher risk of rapid progression and support more targeted clinical trials. United Therapeutics (NasdaqGS:UTHR) is drawing attention as it pairs clinical momentum with a...